In addition, mutations in the core promoter region of TERT have been shown to increase the transcriptional activity of telomerase and to be an independent marker of poor prognosis in various cancers, such as glioblastoma, thyroid carcinoma44, 45, 46, 47, 48, and cutaneous conventional melanoma16, 17. This evidence concerns the gene TERT and glioblastoma.